We showed that miR-34a/c inhibited the expression of oncogenic PDGFR-α and PDGFR-β, and overexpression of miR-34a/c enhanced TRAIL sensitivity in LC cell lines (77). The gene discussed is TNFSF10; the disease is laryngotracheoesophageal cleft.